loading
전일 마감가:
$57.07
열려 있는:
$57.53
하루 거래량:
230.26K
Relative Volume:
0.20
시가총액:
$9.60B
수익:
$29.52M
순이익/손실:
$-519.21M
주가수익비율:
-17.66
EPS:
-3.26
순현금흐름:
$-520.21M
1주 성능:
+0.34%
1개월 성능:
+20.55%
6개월 성능:
+45.15%
1년 성능:
+176.89%
1일 변동 폭
Value
$56.50
$58.28
1주일 범위
Value
$53.69
$58.28
52주 변동 폭
Value
$20.86
$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name
명칭
Revolution Medicines Inc
Name
전화
415-766-3638
Name
주소
700 SAGINAW DR, REDWOOD CITY, CA
Name
직원
490
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
RVMD's Discussions on Twitter

RVMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
RVMD 57.56 9.60B 29.52M -519.21M -520.21M -3.26
VRTX 447.45 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.52 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.72 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.49 24.49B 3.30B -501.07M 1.03B 11.54

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-07-16 재확인 Needham Buy
2024-07-12 개시 Barclays Overweight
2024-07-08 개시 Jefferies Buy
2024-04-12 재확인 Needham Buy
2024-04-10 업그레이드 Raymond James Outperform → Strong Buy
2024-03-11 개시 Piper Sandler Overweight
2024-01-05 업그레이드 BofA Securities Neutral → Buy
2024-01-04 개시 Wedbush Outperform
2023-11-16 개시 Raymond James Outperform
2023-02-28 업그레이드 JP Morgan Neutral → Overweight
2022-12-14 개시 Needham Buy
2022-10-21 개시 Oppenheimer Outperform
2022-05-20 개시 BofA Securities Neutral
2022-03-01 업그레이드 Stifel Hold → Buy
2021-09-23 개시 Stifel Hold
2021-08-12 다운그레이드 Goldman Buy → Neutral
2021-05-18 개시 Goldman Buy
2020-05-21 개시 H.C. Wainwright Buy
2020-03-09 개시 Cowen Outperform
2020-03-09 개시 Guggenheim Buy
2020-03-09 개시 JP Morgan Neutral
모두보기

Revolution Medicines Inc 주식(RVMD)의 최신 뉴스

pulisher
Nov 19, 2024

Victory Capital Management Inc. Sells 104,851 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Nov 19, 2024
pulisher
Nov 16, 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $61.00 Average Price Target from Brokerages - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Revolution Medicines executive sells shares worth $977,508 By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Revolution Medicines executive sells shares worth $977,508 - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Revolution Medicines' SWOT analysis: stock rises on cancer drug pipeline By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Revolution Medicines' SWOT analysis: stock rises on cancer drug pipeline - Investing.com India

Nov 15, 2024
pulisher
Nov 13, 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

Revolution Medicines (NASDAQ:RVMD) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Issues Pessimistic Estimate for RVMD Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

What is Wedbush's Forecast for RVMD FY2024 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Revolution Medicines' general counsel sells $360,000 in stock - Investing.com India

Nov 09, 2024
pulisher
Nov 09, 2024

Revolution Medicines Stock Soars to All-Time High of $60.53 By Investing.com - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus.com

Nov 09, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP Reduces Stake in Revolution Medi - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Revolution Medicines' general counsel sells $360,000 in stock By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

Revolution Medicines Stock Soars to All-Time High of $60.53 - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Revolution Medicines reports on RAS(ON) inhibitors progress By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 07, 2024

Earnings call: Revolution Medicines reports on RAS(ON) inhibitors progress - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

HC Wainwright Issues Negative Outlook for RVMD Earnings - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

JPMorgan Chase & Co. Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Revolution Medicines Reports Q3 2024 Results and Progress - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Revolution Medicines' SWOT analysis: cancer drug developer's stock potential By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Revolution Medicines CEO Mark A. Goldsmith sells $3.88 million in stock - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines (NASDAQ:RVMD) Sets New 1-Year HighWhat's Next? - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines Inc (RVMD) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines to Participate in Upcoming Investor Conferences - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Revolution Medicines' SWOT analysis: cancer drug developer's stock potential - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Brokerage firm bumps Revolution Medicines stock PT on positive trial data - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

(RVMD) Long Term Investment Analysis - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 01, 2024

Revolution Medicines (NASDAQ:RVMD) Given New $60.00 Price Target at Oppenheimer - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Revolution Medicines (RVMD) Set to Announce Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Allspring Global Investments Holdings LLC Raises Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Revolution Medicines stock hits 52-week high at $51.01 By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Revolution Medicines stock hits 52-week high at $51.01 - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Raymond James & Associates Purchases 116,135 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Purchases 12,744 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Revolution Medicines (NASDAQ:RVMD) PT Raised to $82.00 - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts - BioSpace

Oct 28, 2024
pulisher
Oct 26, 2024

Revolution Medicines reports positive RMC-9805 study results - Investing.com India

Oct 26, 2024
pulisher
Oct 25, 2024

Revolution Medicines reports positive RMC-9805 study results By Investing.com - Investing.com Australia

Oct 25, 2024

Revolution Medicines Inc (RVMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):